The Biomedical Engineering Outlook 2025 provides an overview of the industry’s current landscape, highlighting its growth and innovation. As the global demand for healthcare technologies continues to rise, the report examines emerging trends, key players, and the impact of technological advancements on patient care. It also addresses the challenges and ethical considerations that further drive these innovations, ensuring a balanced perspective on the future landscape of biomedical engineering.
This biomedical engineering report serves as a reference for stakeholders within the industry, investors, policymakers, and economic analysts, providing a snapshot of the industry’s health to map its trajectory for innovation and growth in the coming years.
StartUs Insights Biomedical Engineering Outlook 2025
- Executive Summary
- Introduction to the Biomedical Engineering Report 2025
- What data is used in this Biomedical Engineering Report?
- Snapshot of the Global Biomedical Engineering Industry
- Funding Landscape in the Biomedical Engineering Industry
- Who is Investing in Biomedical Engineering Companies?
- Emerging Trends in the Biomedical Engineering Industry
- 5 Innovative Biomedical Engineering Startups
Executive Summary: Biomedical Engineering Report 2025
This report is created using data obtained from the Big Data and AI-powered StartUs Insights Discovery Platform, covering more than 4.7 million global companies, as well as 20K+ technologies and emerging trends. We also analyzed a sample of 2050+ biomedical engineering startups developing innovative solutions to present five examples from emerging biomedical engineering industry trends.
- Industry Growth Overview: The database includes 2051 startups. Moreover, the annual growth rate stands at 15.12%.
- Manpower & Employment Growth: The industry employs 49.5K workers globally and the employee growth reached about 4K in the last year.
- Patents & Grants: Over 370 patents filed by more than 250 applicants, with a yearly patent growth rate standing at 29.89%. In addition, more than 510 grants were awarded.
- Global Footprint: Significant hubs include the USA, India, the UK, Canada, and Australia. Leading city hubs are London, New York City, Sydney, Melbourne, and Tehran.
- Investment Landscape: Average investment value per round stands at USD 7.9 million. More than 110 investors actively participated while over 430 funding rounds closed, spanning 140 companies.
- Top Investors: Some of the top investors include National Science, Y Combinator, and Start Up Chile. The total investment exceeds USD 14 million from the top investors.
- Startup Ecosystem: Five innovative startups include Envoya (polymer-based nanoparticles delivery), YGION Biomedical (tumor immunity treatment), Ruifu Biomedical (neuroregeneration & tissue repair), BioMavericks (AI-powered biomarker discovery tools), and Bioniks (bacterial cellulose production).
- Recommendations for Stakeholders: Companies should collaborate with innovative startups to leverage new technologies and approaches, enhancing their competitive advantage and improving market responsiveness. Governments also have a key role to play in ensuring good policies that protect against ethical concerns while encouraging innovation. This need should foster partnerships between engineers, healthcare professionals, and policymakers to ensure that products meet clinical needs and address real-world challenges.
Explore the Data-driven Biomedical Engineering Future Outlook for 2025
The Biomedical Engineering Report 2025 uses data from the Discovery Platform and encapsulates the key metrics that underline the sector’s dynamic growth and innovation.
The heatmap of the report provides a visual overview of the startup ecosystem. Our database comprises 2051 startups out of over 7630 companies. Industry growth saw an increase of 15.12% over the last year. Additionally, our database highlights key achievements, including over 370 patents and more than 510 grants awarded.
Globally, the industry supports a workforce of 49K+ individuals, with employee growth reaching 4K in the past year alone. The heatmap also emphasizes the significant hubs contributing to this ecosystem. The top five country hubs are the USA, India, the UK, Canada, and Australia. Meanwhile, the leading city hubs are London, New York City, Sydney, Melbourne, and Tehran.
What data is used to create this biomedical engineering report?
Based on the data provided by our Discovery Platform, we observe that the biomedical engineering industry ranks among the top 5% in the following categories relative to all 20K topics in our database. These categories provide a comprehensive overview of the industry’s key metrics and inform the industry’s short-term future direction.
- News Coverage & Publications: Over 1670 news articles were published about biomedical engineering in the last year.
- Funding Rounds: Our database includes data on more than 430 funding rounds.
- Manpower: The industry employs 49K workers globally. In the last year, it added about 4K new employees.
- Patents: Over 370 technologies in the industry were registered for patents.
- Grants: The industry received over 510 grants.
- Yearly Global Search Growth: Yearly global search growth for the industry stands at 9.74%.
A Snapshot of the Global Biomedical Engineering Industry
The biomedical engineering industry report presents data showcasing growth and activity. The annual growth rate stands at 15.12% with 2051 startups, reflecting the entrepreneurial activity. The yearly patent growth rate stands at 29.89%.
Company stage information reveals diverse development phases within the industry. There are over 50 early-stage startups, that highlight the sector’s innovative and exploratory nature. Additionally, more than 30 companies underwent mergers and acquisitions. This indicates a market for consolidation and growth.
In addition, over 370 technologies in the industry filed for patents by 250+ applicants. China leads as the top issuer with over 310 patents, followed by the USA with more than 30.
Explore the Funding Landscape of the Biomedical Engineering Industry
Investment activity in the industry showcases an average investment value per round of USD 7.9 million. Over 110 investors actively participated with more than 430 funding rounds closed. These investments span 140 companies, indicating the diverse interest in the industry’s opportunities.
This data highlights the industry’s growth, innovative efforts, and investment activity for its future trajectory.
Who is Investing in Biomedical Engineering?
The top investors in the industry have collectively contributed more than USD 14 million, showcasing strong financial support for the sector’s growth and innovation. Here is a detailed list of these leading investors, the number of companies they have backed, and their respective investment values:
- National Science supported 4 companies, with a total funding of USD 560K.
- Y Combinator contributed to 2 companies, with a combined funding of USD 250K.
- Start Up Chile backed 2 companies, providing total funding of USD 120K.
- TF Capital funded at least 1 company, with an investment of USD 9 million.
- MicroVentures financed at least 1 company, with a total investment of USD 4 million.
These investments reflect the financial contributions from different sources, underlining the interest in the industry’s potential.
Access Top Biomedical Engineering Innovations & Trends with the Discovery Platform
Biomechanics focuses on the study of mechanical principles applied to biological systems. With over 2210 companies identified and employing 62700 individuals, the trend saw 5400 new hires in the last year. However, it experiences an annual growth rate decline of 4.98%.
Immunotherapeutics grows as a trend in cancer treatment and autoimmune disease management. With over 260 companies and 10800 employees, the field saw the addition of 1200 new employees in the past year. The annual growth rate of 12.78% highlights the sector’s expansion as it develops therapies that harness the body’s immune system to combat diseases.
Biomaterials develop materials that interact with biological systems for medical purposes. Over 1850 companies employing 85K+ people, this trend sector hired 7700 people in the last year. It showcases an annual growth rate of 13.49%.
5 Top Examples from 2050+ Innovative Biomedical Engineering Startups
The five innovative startups showcased below are picked based on data including the trend they operate within and their relevance, founding year, funding status, and more. Book a demo to find promising startups, emerging trends, or industry data specific to your company’s needs and objectives.
Envoya offers Polymer-Based Nanoparticles Delivery
US-based startup Envoya leverages bio-compatible nanoparticles to target mutated genes. The startup optimizes these nanoparticles using machine learning, to engineer them for specific payload delivery for targeting tissues and cells. This technology uses fabricated, polymer-based nanoparticles for the delivery of large payloads and multiple dosing. With this, Envoya overcomes the primary barriers in gene therapy and enhances the delivery systems to impact patient care and health outcomes.
YGION Biomedical develops Tumor Immunity Treatment
Austrian startup YGION Biomedical develops a treatment that harnesses the body’s immune system to target and eliminate cancer cells. YGION Biomedical’s technology platform, YGNITE, incorporates next-generation sequencing and in-house bioinformatics to identify and select therapeutically relevant neoepitopes. These neoepitopes then link to YGION Biomedical’s proprietary CARGONAUT carrier system, which induces a tumor-specific immune response. The technology targets immune-modulating carrier that delivers neoepitope peptides to professional antigen-presenting cells, activating them for effective cross-presentation. This delivery and stimulation approach mimics the body’s natural antigen presentation process for an immune response.
Ruifu Biomedical provides Neuroregeneration & Tissue Repair
Based in Taiwan, Ruifu Biomedical provides high-purity exosomes for nerve regeneration and tissue repair. The startup’s proprietary technology isolates neural stem cell exosomes, rich in specific miRNAs that stimulate the proliferation and differentiation of neural cells. Additionally, it produces mesenchymal stem cell exosomes loaded with growth factors to aid tissue repair and modulate immune cell balance, contributing to their hypoallergenic and non-cytotoxic properties. Furthermore, its microbial ferment essence offers tissue repair solutions for the skin and gastrointestinal tract.
BioMavericks uses AI-powered Biomarker Discovery Tools
UK-based startup BioMavericks leverages AI to analyze multilayered data from genomic sequences for identifying biomarkers. This process pinpoints potential targets and verifies their clinical relevance through validation, integrating life sciences with bioinformatics. BioMavericks’ custom oligonucleotides ensure that the biomarkers identified enhance early cancer detection and support medical needs that depend on accurate biomarker identification.
Bioniks produces Bacterial Cellulose
Italian startup Bioniks manufactures bacterial cellulose-based biomaterials, derived sustainably from the waste of kombucha production. This process utilizes the symbiotic culture of bacteria and yeast (SCOBY) as a primary source, offering an eco-friendly alternative to plant-derived cellulose. Bacterial cellulose from Bioniks features fibers thinner than those of plant-based cellulose, forming a highly porous, three-dimensional network. This material finds diverse applications across industries, including textiles, pharmaceuticals, and agriculture, due to its purity, crystallinity, and water-binding capacity.
Gain Comprehensive Insights into Biomedical Engineering Trends, Startups, or Technologies
The biomedical engineering industry grows with innovation and investment. The newest technologies such as advanced prosthetics, bioengineered tissues, and diagnostic tools offer advanced medical solutions. The sector’s growth is showcased with financial backing and a focus on research and development. As the industry evolves, it provides healthcare advancement, improving the quality of life for patients worldwide. Reach out to explore all 2050+ startups and scaleups, as well as all industry trends impacting biomedical engineering companies.
